The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
A growing number of young people are receiving prescriptions for GLP-1 weight loss medications like Ozempic and Wegovy. Janet ...
Nestlé released a similar announcement on September 18, 2024, revealing an entirely new line of GLP-1-friendly foods under ...
Medpage Today on MSN2d
Bariatric Surgeons Being Put Out of Work by GLP-1 DrugsThe GLP-1 drugs are "truly causing a lot of disruption for the surgeons and for the programs, and for patients," Thomas Tsai, ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 With the growing popularity of weight loss drugs like Ozempic, Wegovyn, ...
Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback